Are CD4+CD25-Foxp3+cells in untreated new-onset lupus patients regulatory T cells?
Open Access
- 12 October 2009
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (5) , R153
Abstract
Introduction: Our previous study has reported that, in patients with untreated new-onset lupus (UNOL), there was an abnormal increase in the number of CD4+CD25-Foxp3+ T cells that correlated with disease activity and significantly decreased after treatment. However, little is known about the nature of this cell entity. The aim of this study was to explore the nature of abnormally increased CD4+CD25-Foxp3+ T cells in UNOL patients. Methods: The expressions of surface (CD4, CD25, CD127, chemokine receptor 4 [CCR4], glucocorticoid-induced tumor necrosis factor receptor [GITR], and cytotoxic T lymphocyte-associated antigen 4 [CTLA-4]) and intracellular (Foxp3) molecules as well as cytokine synthesis of peripheral blood mononuclear cells from 22 UNOL patients were analyzed by flow cytometry. The proliferative and suppressive capacities of different T-cell subgroups from UNOL patients were also assessed. Results: In UNOL patients, the percentages of CD127low/- in CD25high, CD25low, and CD25- subpopulations of CD4+Foxp3+ T cells were 93.79% ± 3.48%, 93.66% ± 2.31%, and 91.98% ± 2.14%, respectively (P > 0.05), whereas the expressions of Foxp3 showed significant differences in CD25high (91.38% ± 2.57%), CD25low (71.89% ± 3.31%), and CD25- (9.02% ± 2.21%) subpopulations of CD4+CD127low/- T cells (P < 0.01). The expressions of surface CCR4, GITR, and CTLA-4 on CD4+CD25-Foxp3+ T cells were significantly less than CD4+CD25+Foxp3+ T cells (P < 0.05). Moreover, unlike CD4+CD25+Foxp3+ T cells, CD4+CD25-Foxp3+ T cells also synthesized interferon-gamma, interleukin (IL)-4, IL-2, and IL-17 (P < 0.05), though less than CD4+CD25+Foxp3- T cells. The suppressive capacity was most prominent in CD4+CD25highCD127low/-, followed by CD4+CD25lowCD127low/-. CD4+CD25-CD127- T cells showed the least suppressive capacity, which was similar to the effector T cells. Conclusions: CD4+CD25-Foxp3+ T cells in UNOL patients are different from regulatory T cells, both phenotypically and functionally. CD127 is not an appropriate surface marker for intracellular Foxp3 in CD4+CD25- T cells.Keywords
This publication has 16 references indexed in Scilit:
- Clinical significance of increased CD4+CD25 Foxp3+ T cells in patients with new-onset systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2008
- Regulatory T cells in systemic lupus erythematosus: past, present and futureArthritis Research & Therapy, 2008
- Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cellsInternational Immunology, 2004
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- CD4+CD25+ Immunoregulatory T CellsImmunity, 2002
- Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-toleranceNature Immunology, 2002
- Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T CellsJournal of Experimental Medicine, 2001
- Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4Journal of Experimental Medicine, 2000
- Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokineInternational Immunology, 1999
- Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene.Journal of Experimental Medicine, 1995